ICON Public Limited Company gains after Oakmark highlights its performance amid broader market focus on AI-driven stocks.
ICON Public Limited Company (NASDAQ:ICLR) surged following Oakmark U.S. Concentrated Strategy’s Q2 2026 investor letter, which emphasized the firm’s net book-to-bill strength. The stock closed at $180.24 on July 28, 2026, reflecting a 2.96% one-month return but a 0.69% decline over the past year. ICON’s market capitalization stands at $13.91 billion.
Oakmark’s strategy underperformed the Russell 1000 Value Index’s 13.87% return in Q2, as U.S. equities rose broadly with technology and industrials leading gains. The firm maintained its value-focused approach, avoiding AI-driven market trends despite concentrated leadership in the sector.
The letter highlighted ICON as a key holding, noting its role as a clinical research organization serving pharmaceutical, biotechnology, and medical device industries.